TOKYO (Reuters) - Japan's health ministry will investigate the Japanese unit of Novartis AG, Japanese media said, after a ministry panel said it may have violated Japanese law when it cited studies based on manipulated data to promote its blood pressure drug Diovan. "Japan, as a part of its growth strategy, is pushing for high-quality clinical studies necessary to develop pharmaceuticals originating in Japan," a ministry investigative committee said in a draft interim report. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment